1. Home
  2. PRTA vs HSII Comparison

PRTA vs HSII Comparison

Compare PRTA & HSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • HSII
  • Stock Information
  • Founded
  • PRTA 2012
  • HSII 1953
  • Country
  • PRTA Ireland
  • HSII United States
  • Employees
  • PRTA N/A
  • HSII N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • HSII Diversified Commercial Services
  • Sector
  • PRTA Health Care
  • HSII Consumer Discretionary
  • Exchange
  • PRTA Nasdaq
  • HSII Nasdaq
  • Market Cap
  • PRTA 809.8M
  • HSII 904.3M
  • IPO Year
  • PRTA N/A
  • HSII 1999
  • Fundamental
  • Price
  • PRTA $9.20
  • HSII $37.96
  • Analyst Decision
  • PRTA Buy
  • HSII Buy
  • Analyst Count
  • PRTA 9
  • HSII 2
  • Target Price
  • PRTA $54.57
  • HSII $48.00
  • AVG Volume (30 Days)
  • PRTA 557.1K
  • HSII 161.3K
  • Earning Date
  • PRTA 05-07-2025
  • HSII 05-05-2025
  • Dividend Yield
  • PRTA N/A
  • HSII 1.58%
  • EPS Growth
  • PRTA N/A
  • HSII N/A
  • EPS
  • PRTA N/A
  • HSII 0.41
  • Revenue
  • PRTA $135,157,000.00
  • HSII $1,098,573,000.00
  • Revenue This Year
  • PRTA N/A
  • HSII $5.41
  • Revenue Next Year
  • PRTA $131.71
  • HSII $3.97
  • P/E Ratio
  • PRTA N/A
  • HSII $94.66
  • Revenue Growth
  • PRTA 47.92
  • HSII 6.98
  • 52 Week Low
  • PRTA $9.10
  • HSII $29.03
  • 52 Week High
  • PRTA $25.42
  • HSII $49.02
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 26.58
  • HSII 34.94
  • Support Level
  • PRTA $9.30
  • HSII $37.69
  • Resistance Level
  • PRTA $10.45
  • HSII $42.17
  • Average True Range (ATR)
  • PRTA 0.81
  • HSII 1.87
  • MACD
  • PRTA -0.15
  • HSII -0.32
  • Stochastic Oscillator
  • PRTA 2.77
  • HSII 4.49

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About HSII Heidrick & Struggles International Inc.

Heidrick & Struggles International Inc is a leadership advisory firm providing executive search and consulting services to businesses and business leaders world wide. The company's operating segments includes the executive search business which operates in the Americas; Europe; Asia Pacific and On-Demand Talent and Heidrick Consulting. It generates maximum revenue from the Americas.

Share on Social Networks: